Concepedia

Michael E. Kuligowski

ME

15

Publications

942

Citations

13

H-Index

1989

Active since

Affiliations

Incyte (United States)(Current)

Probity Medical Research

Wroclaw Medical University

Icahn School of Medicine at Mount Sinai

Oregon Health & Science University

Michael E. Kuligowski is an author at Incyte (United States) specializing in medicine, dermatology, and allergy medicine.

Top concepts

Publications per year

1989–2024

15

Publications

15

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies

Kim Papp, Jacek C. Szepietowski, Leon Kircik et al. · Journal of the American Academy of Dermatology · 2021 · 274 citations

Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream

Brian Kim, Michael Howell, Kang Sun et al. · Journal of Allergy and Clinical Immunology · 2019 · 215 citations · Full text

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

Brian Kim, Kang Sun, Kim Papp et al. · Journal of the American Academy of Dermatology · 2020 · 103 citations · Full text

Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies

Kim Papp, Jacek C. Szepietowski, Leon Kircik et al. · Journal of the American Academy of Dermatology · 2022 · 82 citations · Full text

Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies

Xiaohua Gong, Xuejun Chen, Michael E. Kuligowski et al. · American Journal of Clinical Dermatology · 2021 · 65 citations · Full text

Rows per page

1–5 of 15